chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sinus infection; Dizziness; Neck pain; Ear pain in left side; Arm numbness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness). The patient was treated with IBUPROFEN (ADVIL ULTRA [IBUPROFEN]) at an unspecified dose and frequency; DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency and XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection), DIZZINESS (Dizziness), NECK PAIN (Neck pain), EAR PAIN (Ear pain in left side) and HYPOAESTHESIA (Arm numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concurrent medication was reported by patient.   This case was linked to MOD-2021-090350 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received on 27-5-2021 contains no new information.
About 1 hr. after vax, entire shoulder (injection site) hurt & accross the scapula & inside the armpit hurt (ached). Didn't sleep that night. 11/3/99, went to Dr. & he Dx: a bacterial infection from site of flu shot. Tx: 10-day Cedax 400mg.
Pain, swelling at injection site, then flu like syndrome with low fever about 100 F, aching knee joints for only one day on 7/18/2018.
pain, swelling, and bruising local reaction to right deltoid; bilateral supraclavicular lymphadenopathy, bilateral neck pain and stiffness
pt recvd DTP/HIB/OPV on 7DEC92; 8DEC92 urticaria began examined 9DEC92 extensive urticarial body; lungs clear; treated w/DPH;
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 04/10/2021. PATIENT FULLY VACCINATED ON 02/27/2021.
Right arm is discolored with purple tint. Blanches on touch. Discoloration from right shoulder down to right wrist. Can see where the bandaids were placed (white colored where band aids were placed).
Covid-19 Infection. Symptoms included nasal congestion, headache, fatigue, and burning of eyes for 3 days. Treatment included symptomatic relief with Paracetamol 500mg thrice daily, Leveoceterizine and Vitamin C supplements.
pneumonia due to COVID 10, lactic acidosis, respiratory failure requiring intubation, toxic metabolic encephalopathy
Phone call from mother reporting knot Right thigh at site of DTaP from 4/20/04  first noted 5/9/04.  Denies that site has redness, increased skin temperature. Child afebrile.Instructed that it is possible to have a knot a couple of weeks after.  Dr. eval 5/10/04 contributed knot to tightened muscle during vaccination and instructed to apply ice after future vaccinations.
Hot flashes; Burning sensation; metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced BURNING SENSATION (Burning sensation) and DYSGEUSIA (metallic taste). On an unknown date, the patient experienced HOT FLUSH (Hot flashes). At the time of the report, BURNING SENSATION (Burning sensation), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient was sitting s/p vaccination waiting 15 min. She became diaphoretic, nauseous, and pale. She vomited twice. She stated that she thought she had a panic attack. Her vital signs were normal at all times. Last set of vitals 97.6 po, 126/84, 77, 98%
Patient reported that immediately after receiving the second vaccine (Gardasil), he had blurry vision so bad that he could not see, felt dizzy,  and that he had an upset stomach. Pt guided to cot to lay down, but he asked to stay seated, resting his head on the wall behind him. Parent stated child had eaten breakfast, but staff offered an orange juice to see if it would help to calm upset stomach and monitored child for 10 minutes after injection. Child stated that his vision improved and his stomach felt better. Patient/child was alert through process and able to communicate his needs. Parent was comfortable and staff felt child had improved enough to leave after improvement of symptoms.
this is one of 2 hosp employees to devel a 10cm area of swelling, pain, warmth & a nodule @ site of flu vax;pt also exp gen aching, malaise, & diarrhea;diarrhea persisted for 72 hr;pt was seen in ER & tx w/DPH & ice;
High fever of 105.0. Lethargic. Flush face. Stopped babbling and saying words. Slight regression.
DULL HEADACHE BEHIND THE RIGHT EYE; FLARE UP; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (FLARE UP) and HEADACHE (DULL HEADACHE BEHIND THE RIGHT EYE) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis, Ankylosing spondylitis and Ulcerative colitis.    No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In November 2021, the patient experienced CONDITION AGGRAVATED (FLARE UP). On an unknown date, the patient experienced HEADACHE (DULL HEADACHE BEHIND THE RIGHT EYE). In 2021, CONDITION AGGRAVATED (FLARE UP) had resolved. At the time of the report, HEADACHE (DULL HEADACHE BEHIND THE RIGHT EYE) had resolved.            Concomitant medication was not reported.  In Nov-2021, patient experienced flare up of condition. On an unknown date, patient experienced dull headache behind right eye. On 31-Jul-2021, patient again experienced dull headache behind right eye. Treatment details were not reported.  It was unknown if patient was enrolled in a covid-19 vaccine trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-623627.
Patient reported that her arm was still sore 1 month after receiving her first dose of the Pfizer Covid vaccine. She also said she had some swelling and bruising around her elbow.
Approximately 10 minutes following the administration of the first dose of the Moderna COVID vaccine, the patient complained of numbness and mild swelling in her mouth and throat.  Physical exam showed mild swelling in her posterior pharynx, erythema and white spots on the roof of her mouth.  Patient denied any shortness of breath, facial swelling, rash or dysphagia.
After receiving the Shingrix shot on 7/10/2019, the patient reported nausea/vomiting and erythema around the injection site for the next 3 days. After the 3 days, the symptoms resolved. The patient requested to not receive the second shot of the series.
I began to feel exhausted and had to stop a biking workout I was doing.  (Previously a competitive age-group triathlete).  I began to get more and more tired over the next few weeks, until I could not exercise at all and even had difficulty working and perfoming normal daily activities like cooking, cleaning, shopping, etc.
Developed two open sores (less than 1/2 inches) near the injection site.  Picture attached.
Pt received vaccinations, Then as she was exiting the clinic she passed out, hitting her head and neck in multiple locations.  Pt was provided first aid by nurses, Neuro signs were checked, Blood pressure was checked.  Pt was evaluated and an ambulance was called based on patient's c/o neck pain, tiredness.
Home antigen positive; Home antigen positive; Booster; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 12Oct2021 (Lot number: EL3247) as dose 3 (booster), single, administration date 18Feb2021 (Lot number: EL3247) as dose 2, single and administration date 27Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunization at a workplace clinic. The patient's relevant medical history and concomitant medications were not reported. Clinical course: On 09Jan2022, the patient experienced dry cough symptom with a positive home antigen  test on the same day.  The following information was reported: IMMUNISATION (medically significant) with onset 12Oct2021, outcome "unknown", described as "Booster"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Jan2022, outcome "recovering" and all described as "Home antigen positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (09Jan2022) positive. It was unknown if therapeutic measures were taken as a result of immunisation, vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: A causal relationship to the suspect drug cannot be excluded for events vaccination failure/booster and COVID-19. This case will be reassessed upon receipt of additional information.,Linked Report(s) : US-PFIZER INC-202200037242 same reporter/ product, different patient.
Mother reports that roughly 30 minutes after injection they were traveling in car and he vomited a small amount and then complained of not feeling well after a rew hours. He did eat lunch.
Headache, Arthralgia, Fever, fatigue, insomnia Narrative:
The patient called the pharmacy to state she had extreme muscle pain and aches after receiving the vaccine yesterday, to the point of barely being able to walk today. The patient was advised that muscle aches is listed in the side effect profile and she could use ibuprofen, acetaminophen, ice and other home remedies to ease the symptoms and to call the doctor if they did not improve or became worse. The patient chose to have the pharmacy call the doctor's office to notify them of the symptoms and wanted a return call from the doctor's office. Doctor's nurse said she would take care of the call.
Arm stiffened, no redness or edema, was unable to to move arm. Painful. Limited movement and moderate pain after 2 weeks. Used Tylenol twice a day and applied ice for several days.
I had a UTI; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 22Sep2021 (Lot number: EW0162) at the age of 49 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Chronic Pain disorder" (unspecified if ongoing); "Blood Pressure" (unspecified if ongoing), notes: I take Blood Pressure medication. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01, LOT# EW0175), administration date: 30Aug2021, when the patient was 49 years old, for Covid-19 immunization. The following information was reported: URINARY TRACT INFECTION (non-serious) with onset 12Nov2021, outcome "not recovered", described as "I had a UTI". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of urinary tract infection.   Additional information: The patient had the Pfizer vaccine on 23Sep2021 and on 04Oct2021, the patient had a UTI, it's first UTI the patient ever had in 49 years they treated it and then the patient got a secondary UTI yesterday 12Nov which is just you know very short period time away from the first one so the doctor and the patient discussed that it could be a side effect of the Pfizer vaccine since there is some literature out there and some reporting that it is some length neurology issue in women 44 to 65 and also men but, the patient don't have age range for them. So, the patient would like to know is this going to go away or am the patient going to have to live life getting a UTI every single month having a beyond antibiotic which will ultimately lead me to be antibiotic resistance and also the patient is supposed to get a booster in Mar and the patient doesn't think the patient is going to get it if this is you know what's going to happen to the patient is side effect. The patient has chronic Pain disorder and the patient take pain medication (Further not clarified) for that the patient has bit of hypertension. the patient takes Blood Pressure medication (Further Not clarified) for that other than that the patient takes a natural vitamin. Vitamin B12, Vitamin C, Vitamin D and little bit of zinc the patient wouldn't be taking Vitamin C you know what the patient mean that's all the medications. The patient had not diagnosed with covid prior vaccination.  No follow-up attempts are possible. No further information is expected.
Pt noted an itchy red, raised rash on her right upper arm at night. She reports that site hurt ever since the immunization but itching developed on 3/7/15.
Severe body aches, nausea Two days later: swollen lymph nodes in armpit One week later: skin rash at site
Maculopapular rash. Arthralgia of the lower extremities currently with these symptoms. Symptomatic treatment being given at home.
confused; face and hands felt a little tingly; heart was racing; chills; fever; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused), PARAESTHESIA (face and hands felt a little tingly), PALPITATIONS (heart was racing), CHILLS (chills) and PYREXIA (fever) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included CANNABIDIOL (CBD OIL) for an unknown indication. On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and MYALGIA (arm was sore). On 22-May-2021, the patient experienced CONFUSIONAL STATE (confused), PARAESTHESIA (face and hands felt a little tingly) and PALPITATIONS (heart was racing). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency; Bed rest (Bed rest) for Confusional state; Bed rest (Bed rest) for Paraesthesia; Bed rest (Bed rest) for Palpitations; Bed rest (Bed rest) for Chills; Bed rest (Bed rest) for Pyrexia and Bed rest (Bed rest) for Myalgia. On 22-May-2021, CONFUSIONAL STATE (confused), PARAESTHESIA (face and hands felt a little tingly), PALPITATIONS (heart was racing), CHILLS (chills), PYREXIA (fever) and MYALGIA (arm was sore) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient 9-10-18 at 12:00 PM presented to the pharmacy to request ranitidine. Patient asked me to look at her left arm. It presented red, swollen and warm to touch but it was localized, she said it had begun the evening after the vaccine and had not gotten worse. I advised to keep an eye in case any signs of infection. I followed up 6 hrs later and there was no change. Patient had an existing doctor's visit on 9-11-18 and she will ask MD to advise on the swelling. I explained to the patient that one of the known adverse effects of BOOSTRIX was redness and swelling at injection site. Patient stated there was mild pain at injection site but no other side effects or adverse effects and no fever.
At 23 hours after injection, fever began. The fever was followed by headache, tiredness, and soreness. The fever ultimately rose to 103.3 and stayed around there for several hours. I took Tylenol for the symptoms. I woke up in the night with chills and night sweats. Into the second day of symptoms, only a slight headache and tiredness remain. Continuing with Tylenol for treatment.
could not move his neck stating the area was the size of a quarter; neck, pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 81 year-old male patient received bnt162b2 (BNT162B2), administration date 07Mar2021 (Lot number: EN6203) at the age of 81 years as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HYPOKINESIA (non-serious) with onset 08Mar2021, outcome "not recovered", described as "could not move his neck stating the area was the size of a quarter"; NECK PAIN (non-serious) with onset 08Mar2021, outcome "not recovered", described as "neck, pain". Therapeutic measures were taken as a result of hypokinesia, neck pain.  Follow-up (11Mar2021): This is a follow-up spontaneous report from two contactable consumers. A contactable consumer (wife) and a contactable 81-year-old consumer (patient) reported information included.  No follow-up attempts are possible. No further information is expected.
Vaccine in refrigerator was refrozen for 12 hours then put in refrigerator again and later administered; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine in refrigerator was refrozen for 12 hours then put in refrigerator again and later administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jan-1900, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine in refrigerator was refrozen for 12 hours then put in refrigerator again and later administered). At the time of the report, PRODUCT STORAGE ERROR (Vaccine in refrigerator was refrozen for 12 hours then put in refrigerator again and later administered) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were provided No  Concomitant medications were provided
fever, sore lt arm from shoulder to elbow, swelling of arm specifically medial side above elbow w/erythema; ATB prescribed by MD 30SPE93 unsure if inflammation related to inject;
Delayed injection site reaction occurred on day 4 post second vaccine. Arm swollen, hot to the touch, tight, itching and painful.  Swelling, heat, pain, itching continued to spread from injection site in left deltoid down entire upper arm to elbow by day 8 post vaccine (today).
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: EN-6207) and on 02Apr2021 as dose 2, single (Lot number: ER-8734) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 08Dec2021 as dose 3 (booster), single (Lot number: 030H216) for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "low thyroid" (unspecified if ongoing); "insomnia" (unspecified if ongoing); "Known allergies: Only narcotics" (unspecified if ongoing), notes: Known allergies: Only narcotics. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient received COVID 19 Treatment with Paxlovid, started on 11Aug2022.
10 minutes after receiving Gardasil #1-patient became dizzy,hot, blacked out. Patient recovered completely after 20 minutes.
Headache pain that start after receiving initial COVID vaccine/Pain is located on right side of head and radiates across the front of head; This is a spontaneous report from a Non-contactable consumer(patient). A 76-year-old male patient received first dose of bnt162b2 (BNT162B2), via unspecified route of administration on unknown date in Feb2021 at single dose for covid-19 immunization and received second dose of bnt162b2 (BNT162B2; Formulation: Solution for injection), via unspecified route of administration on unknown date single dose for covid-19 immunization. Relevant medical history includes allergic to Morphine, Cipro, Voltaren, Acetaminophen, Amoxicillin, Sulfa. Concomitant medications were not provided. Since the vaccination, the patient had not tested positive for COVID-19. It was reported that headache pain that start after receiving initial COVID vaccine. Did start improving approximately 20 days after initial vaccine but then came right back after 2nd COVID vaccine. Pain is located on right side of head and radiates across the front of head. It is constant but does wax and wane some. Not affected by bright lights or loud sounds. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient diagnosed with COVID-19. Treatment received for the adverse event with medications. The outcome of the events was "Unknown".  Information on the lot/batch number has been requested.  No follow attempts are possible. No further information is expected.